The good rays: let them shine! Poul F. Høilund-Carlsen Editorial Open access 17 December 2018 Pages: 271 - 275
A new frontier for amyloid PET imaging: multiple sclerosis Silvia MorbelliMatteo BaucknehtFlavio Nobili Editorial 15 December 2018 Pages: 276 - 279
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes Anna M. PietroboniTiziana CarandiniGiorgio Marotta Original Article 21 October 2018 Pages: 280 - 287
Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer’s disease in mild cognitive impairment patients Andrea CiarmielloAntonio TartaglioneLuigi Mansi Original Article Open access 22 September 2018 Pages: 288 - 296
Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation Otakar BelohlavekMonika JaruskovaKaterina Simonova Original Article Open access 29 August 2018 Pages: 297 - 303
Dual-phase [18F]florbetapir in frontotemporal dementia Michael AsgharRainer HinzStephen F. Carter Original Article Open access 19 December 2018 Pages: 304 - 311
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18F]FDG PET Sabine HellwigLars FringsPhilipp T. Meyer Original Article Open access 10 August 2018 Pages: 312 - 323
The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer’s disease Alice JaillardMatthieu VanhoutteFranck Semah Original Article 28 August 2018 Pages: 324 - 333
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease Fabrizio De CarliFlavio Nobilifor the Alzheimer’s Disease Neuroimaging Initiative Original Article 31 October 2018 Pages: 334 - 347
Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease Stephen F. CarterKonstantinos ChiotisElena Rodriguez-Vieitez Original Article Open access 04 December 2018 Pages: 348 - 356
Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias Hye Joo SonJungsu S. OhJae Seung Kim Original Article 14 August 2018 Pages: 357 - 366
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding Katarina VarnäsZsolt CselényiAndrea Varrone Original Article Open access 01 October 2018 Pages: 367 - 375
Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders Iñigo GabilondoVerónica LlorensJuan Carlos Gómez-Esteban Original Article 15 October 2018 Pages: 376 - 384
Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy Valentina GaribottoMichael WissmeyerFabienne Picard Original Article 29 September 2018 Pages: 385 - 395
Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue Michel KooleJune van AalstKoen Van Laere Original Article 18 August 2018 Pages: 396 - 406
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients Adrienne Müller HerdeRoger SchibliSimon M. Ametamey Original Article 05 October 2018 Pages: 407 - 420
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer Benjamin HouduCharline LasnonNicolas Aide Original Article 14 September 2018 Pages: 421 - 428
18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules Silvia TaralliValentina ScolozziMaria Lucia Calcagni Original Article 08 December 2018 Pages: 429 - 436
Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer Julian KirchnerLino M. SawickiPhilipp Heusch Original Article 03 August 2018 Pages: 437 - 445
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer Seung Hwan MoonJinho KimSe-Hoon Lee Original Article 25 August 2018 Pages: 446 - 454
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients Mubarik A. ArshadAndrew ThorntonEric O. Aboagye Original Article Open access 01 September 2018 Pages: 455 - 466
Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases Kung-Chu HoCheng-Hong TohTzu-Chen Yen Original Article 10 November 2018 Pages: 467 - 477
Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy Ling YuanMichael C. KreisslSijin Li Original Article Open access 31 October 2018 Pages: 478 - 488
18F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice Kirstin A. ZettlitzRichard TavaréAnna M. Wu Original Article 19 November 2018 Pages: 489 - 500
Dynamic whole-body PET imaging: principles, potentials and applications Arman RahmimMartin A. LodgeRichard L. Wahl Review Article 29 September 2018 Pages: 501 - 518
Why should we be concerned about a “g”? Savvas FrangosJohn R. Buscombe Letter to the Editor 06 November 2018 Pages: 519 - 519
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma? Hajira IlyasN. George MikhaeelSally F. Barrington Letter to the Editor 01 November 2018 Pages: 520 - 521
Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer Eric LaffonRoger Marthan Letter to the Editor 30 October 2018 Pages: 522 - 523
First steps in an uncharted territory by WFNMB Dong Soo LeePatricia Bernal TrujilloSavvas Frangos Society Communications 22 November 2018 Pages: 524 - 530
Severe posterior hypometabolism but normal perfusion in a patient with chronic fatigue syndrome/myalgic encephalomyelitis revealed by PET/MRI S. SahbaiP. KauvE. Itti Image of the Month 14 December 2018 Pages: 531 - 532
Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer Benjamin HouduCharline LasnonNicolas Aide Correction 07 December 2018 Pages: 533 - 534
Bertoldo, F., Boccardo, F., Bombardieri, E., Evangelista, L., Valdagni, R. (Eds.) Bone Metastases from Prostate Cancer: Biology, Diagnosis and Management Luigi Mansi Book Review 18 August 2018 Pages: 535 - 535